Rallybio Corporation

NASDAQ: RLYB · Real-Time Price · USD
0.29
0.00 (1.33%)
At close: Jun 03, 2025, 3:59 PM
0.29
-0.21%
After-hours: Jun 03, 2025, 04:36 PM EDT

Rallybio Revenue Breakdown

Period Ending Dec 31, 2024
Collaboration And License Revenue Revenue 636K
Collaboration And License Revenue Revenue Growth n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Selling, General, and Administrative Revenue 4.16M 4.26M 4.13M 4.39M 6.85M 5.19M 6.08M 6.95M 7.17M 6.3M 6.75M 7.48M 6.67M 6.22M 5.02M 3.71M 3.79M 2.59M 1.58M 1.57M 1.93M
Selling, General, and Administrative Revenue Growth -2.44% +3.30% -5.99% -35.95% +32.05% -14.60% -12.63% -3.05% +13.88% -6.70% -9.72% +12.10% +7.25% +23.86% +35.26% -1.98% +46.10% +64.05% +0.64% -18.69% n/a
Research and Development Revenue 5.72M 7.36M 8.24M 12.91M 12.9M 15.89M 13.29M 13.13M 11.2M 10.79M 12.11M 10.14M 7.65M 6.09M 4.96M 6.82M 9.04M 7.5M 5.13M 3.09M 1.91M
Research and Development Revenue Growth -22.16% -10.74% -36.18% +0.09% -18.80% +19.57% +1.20% +17.21% +3.79% -10.88% +19.45% +32.56% +25.50% +22.86% -27.25% -24.55% +20.57% +46.10% +65.91% +61.63% n/a